* This section is for medical professionals only. If you are a patient, please visit another page.

SPARKING
NEW
TREATMENTS

Protocol Number: 228PD201

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study, with an Active-Treatment Dose-Blinded Period, to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of BIIB054 in Subjects with Parkinson’s Disease

Schedule time to speak with the
Principal Investigator for more information.

LEARN MORE
  • A
  • A
  • A
High-contrast Proceed

*Required fields